Approvals/TGA/BIMZELX bimekizumab 160 mg/1 mL solution for injection auto-injector

Approved

STANDARD

BIMZELX bimekizumab 160 mg/1 mL solution for injection auto-injector

Approval Id: aae4e0d623ea58ec
Product Name: BIMZELX bimekizumab 160 mg/1 mL solution for injection auto-injector
Artg Id: 353268
Artg Name: Bimzelx bimekizumab 160 mg/1 mL solution for injection auto-injector
Sponsor: UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Company Detail Path: /organization/ucb-australia-pty-ltd
Artg Date: 2022-03-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/cce850123b52639f37e235b744067c34.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/ed0ab301ebc6560a42d8e1031fa51731.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

aae4e0d623ea58ec

Type

Standard